PharmaShots | Incisive News in 3 Shots

Subscribe Now

atezolizumab

Roche's Tecentriq (atezolizumab) + Paclitaxel Fail to Meet the Primary Endpoint in P-III IMpassion131 Study for Patients with Metastatic Triple-Negative Breast Cancer

Roche's Tecentriq (atezolizumab) + Paclitaxel Fail to Meet the Primary Endpoint in P-III IMpassion131 Study for Patients with Meta...

August 7, 2020

Roche's Tecentriq (atezolizumab) + CT Receive NMPA's Approval as 1L Treatment for Extensive-Stage Small Cell Lung Cancer

Roche's Tecentriq (atezolizumab) + CT Receive NMPA's Approval as 1L Treatment for Extensive-Stage Small Cell Lung Cancer

February 14, 2020

Roche Reports Result of Ipatasertib + Tecentriq (atezolizumab) in P-Ib Study for 1L Patients with Advanced Triple-Negative Breast Cancer (TNBC)

Roche Reports Result of Ipatasertib + Tecentriq (atezolizumab) in P-Ib Study for 1L Patients with Advanced Triple-Negative Breast...

April 1, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us